Teenagers Offer Fresh Perspectives to Combat Obesity

By Staff Writer

October 13, 2023

Teenagers are an unutilised resource in the fight against obesity

New research just published in Obesity Reviews reveals that young people in Europe are increasingly tackling obesity. The European Union supported this research project. Its goal was to understand the perspectives of young adults and adolescents in the country. These individuals will be the future decision-makers and parents. The study aimed to gain insights into their experiences and potential solutions to this health crisis. 

Researchers came to the conclusion that the conventional method of putting all of the emphasis on one’s diet and level of physical activity was insufficient. The problem of obesity in young people is not standalone. Their peer groups, body image, self-confidence, and self-determination significantly influence it. These factors are part of a broader context of their healthcare in general. 

The CO-CREATE Project: A New Approach 

Professor Knut-Inge Klepp directed the CO-CREATE project. The project aimed to reduce the prevalence of childhood obesity. It highlighted the importance of understanding the social and psychological experiences of young people. In addition to focusing on the participants’ physical well-being, this initiative places an emphasis on the importance of bolstering the participants’ psychological fortitude and lobbying for improvements in their surrounding environment.

The project led to a Youth Declaration. This declaration demands major changes in the food environment of young adults and children. Advertisements for unhealthy meals to children under 18 should not be allowed on mass and social media. There should be a tax on sugar-sweetened beverages. The dining environment in schools needs improvement. There should also be more opportunities for various physical activities. 

Having said that, the project also draws attention to the fact that decision-makers should listen to the perspectives of young people. “Excluding young people from democratic participation means their experiences and proposals are ignored,” according to Professor Klepp.

Reference url

Recent Posts

preventive health costs
       

Prevention Valuation: Fund Health, Not Just Savings

💡 Is prevention really saving us money in healthcare?

In their thought-provoking article, “Can Prevention Save Money?”, Baicker and Chandra challenge the prevailing notion that preventive health measures always reduce costs. They argue that while prevention can enhance health outcomes, it often leads to increased spending upfront, and the key lies in evaluating these programs based on their cost-effectiveness instead of expecting them to save money outright.

Curious about the real financial implications of preventive care? Dive into the full analysis to uncover the nuances!

#SyenzaNews #HealthEconomics #costeffectiveness #healthcarepolicy

FDA AI Drug Approval
          

FDA AI Drug Approval

🚀 Are we on the brink of a new era in drug approval?

The FDA’s new AI initiative is set to reshape how we evaluate new therapies by dramatically speeding up the review process. With generative AI tools already cutting down review times from days to mere minutes, this breakthrough will not only enhance efficiency but also enable scientists to focus on more impactful work.

Curious about the implications for market access, patient outcomes, and health economics? Dive into the full article to explore how the future of pharmaceutical approvals is being transformed!

#SyenzaNews #regulatoryaffairs #AIinHealthcare #innovation

HCV treatment advancements
      

HCV Treatment Advancements: Atea Pharmaceuticals KOL Panel

🌍 Are we on the brink of a new era in Hepatitis C treatment?

Atea Pharmaceuticals is hosting a virtual KOL panel on May 14, 2025, featuring top experts discussing the challenges faced by HCV patients and sharing insights from the promising results of their Phase 2 study on bemnifosbuvir and ruzasvir. This could be a game-changer in advancing HCV treatments through ongoing Phase 3 trials.

Don’t miss out on how these developments might reshape the future landscape for HCV patients! Click to read more about the panel and the innovative therapies in the pipeline.

#SyenzaNews #biotechnology #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.